Peak Asset Management LLC Purchases 3,346 Shares of Invesco Dynamic Pharmaceuticals ETF (PJP)

Share on StockTwits

Peak Asset Management LLC raised its stake in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) by 2.6% in the 1st quarter, Holdings Channel reports. The firm owned 133,169 shares of the company’s stock after acquiring an additional 3,346 shares during the period. Invesco Dynamic Pharmaceuticals ETF comprises 3.0% of Peak Asset Management LLC’s holdings, making the stock its 13th largest position. Peak Asset Management LLC’s holdings in Invesco Dynamic Pharmaceuticals ETF were worth $8,679,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in PJP. Patriot Financial Group Insurance Agency LLC increased its stake in shares of Invesco Dynamic Pharmaceuticals ETF by 58.4% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 442 shares of the company’s stock valued at $29,000 after buying an additional 163 shares during the period. Raymond James Financial Services Advisors Inc. grew its stake in Invesco Dynamic Pharmaceuticals ETF by 2.7% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 7,858 shares of the company’s stock worth $490,000 after purchasing an additional 209 shares during the period. Cetera Advisors LLC purchased a new stake in Invesco Dynamic Pharmaceuticals ETF in the first quarter worth $28,000. Liberty Wealth Management LLC purchased a new stake in Invesco Dynamic Pharmaceuticals ETF in the fourth quarter worth $31,000. Finally, JPMorgan Chase & Co. grew its stake in Invesco Dynamic Pharmaceuticals ETF by 8.6% in the first quarter. JPMorgan Chase & Co. now owns 10,100 shares of the company’s stock worth $658,000 after purchasing an additional 800 shares during the period.

PJP stock traded down $0.26 during midday trading on Tuesday, hitting $60.08. The stock had a trading volume of 734 shares, compared to its average volume of 28,414. Invesco Dynamic Pharmaceuticals ETF has a 52-week low of $58.29 and a 52-week high of $74.29.

COPYRIGHT VIOLATION WARNING: “Peak Asset Management LLC Purchases 3,346 Shares of Invesco Dynamic Pharmaceuticals ETF (PJP)” was originally published by Highlight Press and is the property of of Highlight Press. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://highlightpress.com/2019/05/21/peak-asset-management-llc-purchases-3346-shares-of-invesco-dynamic-pharmaceuticals-etf-pjp.html.

Invesco Dynamic Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

Featured Article: What is Blockchain?

Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP).

Institutional Ownership by Quarter for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Receive News & Ratings for Invesco Dynamic Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.